Quest will offer the first FDA-approved blood test to help detect Alzheimer’s-related amyloid pathology in patients with ...

Test to be available for clinical and research use as soon as this summer, building on Quest's pioneering blood-based AD-DetectTM product lin ...

Quest Earnings: Base Business Remains Solid, While Expanding Test Menu Should Reinforce Its Moat Debbie ... Similar to the last five quarters, second-quarter demand for COVID-19 tests fell ...

Quest Diagnostics Incorporated (NYSE:DGX) is one of the 7 most undervalued pot stocks to buy according to analysts.

Quest Diagnostics unveiled a first-to-market blood test available for consumer purchase that helps assess the potential risk of developing Alzheimer’s disease. In adding AD-Detect, a single ...

Now Quest Diagnostics can test you for it without a doctor. News Sports Entertainment Opinion Advertise Obituaries eNewspaper Legals. NEWS. Quest announces 1st PFAS blood test for consumers.

Quest Diagnostics is acquiring liquid biopsy company Haystack Oncology. The startup’s technology is used for identifying cancer patients who need adjuvant therapy. By Frank Vinluan on April 27 ...

Quest Diagnostics has signed up to offer a blood test that can help diagnose Alzheimer’s disease, following its FDA clearance earlier this year. | The Lumipulse G blood test measures the ratio between ...